158 related articles for article (PubMed ID: 38235705)
1. Methylation of NRIP3 Is a Synthetic Lethal Marker for Combined PI3K and ATR/ATM Inhibitors in Colorectal Cancer.
Zhang M; Li X; Herman JG; Gao A; Wang Q; Yao Y; Shen F; He K; Guo M
Clin Transl Gastroenterol; 2024 Mar; 15(3):e00682. PubMed ID: 38235705
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.
Yan W; Wu K; Herman JG; Xu X; Yang Y; Dai G; Guo M
Clin Epigenetics; 2018; 10():69. PubMed ID: 29796120
[TBL] [Abstract][Full Text] [Related]
3. Methylation of
Zheng R; Gao D; He T; Zhang M; Zhang X; Linghu E; Wei L; Guo M
Clin Epigenetics; 2017; 9():50. PubMed ID: 28491151
[TBL] [Abstract][Full Text] [Related]
4. Methylation of TMEM176A is an independent prognostic marker and is involved in human colorectal cancer development.
Gao D; Han Y; Yang Y; Herman JG; Linghu E; Zhan Q; Fuks F; Lu ZJ; Guo M
Epigenetics; 2017 Jul; 12(7):575-583. PubMed ID: 28678648
[TBL] [Abstract][Full Text] [Related]
5. Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth.
Wang Y; He T; Herman JG; Linghu E; Yang Y; Fuks F; Zhou F; Song L; Guo M
Clin Epigenetics; 2017; 9():115. PubMed ID: 29075358
[TBL] [Abstract][Full Text] [Related]
6. Methylation of NRN1 is a novel synthetic lethal marker of PI3K-Akt-mTOR and ATR inhibitors in esophageal cancer.
Du W; Gao A; Herman JG; Wang L; Zhang L; Jiao S; Guo M
Cancer Sci; 2021 Jul; 112(7):2870-2883. PubMed ID: 33931924
[TBL] [Abstract][Full Text] [Related]
7. ATM mutations and E-cadherin expression define sensitivity to EGFR-targeted therapy in colorectal cancer.
Geißler AL; Geißler M; Kottmann D; Lutz L; Fichter CD; Fritsch R; Weddeling B; Makowiec F; Werner M; Lassmann S
Oncotarget; 2017 Mar; 8(10):17164-17190. PubMed ID: 28199979
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of DACH1, a novel Wnt signaling component in colorectal cancer.
Yan W; Wu K; Herman JG; Brock MV; Fuks F; Yang L; Zhu H; Li Y; Yang Y; Guo M
Epigenetics; 2013 Dec; 8(12):1373-83. PubMed ID: 24149323
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing BCL6B induced colorectal cancer proliferation and metastasis by inhibiting P53 signaling.
Hu S; Cao B; Zhang M; Linghu E; Zhan Q; Brock MV; Herman JG; Mao G; Guo M
Am J Cancer Res; 2015; 5(2):651-62. PubMed ID: 25973304
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of voltage-gated potassium ion channel molecule Kv1.3 in mechanisms of colorectal cancer.
He T; Wang C; Zhang M; Zhang X; Zheng S; Linghu E; Guo M
Discov Med; 2017 Mar; 23(126):155-162. PubMed ID: 28472608
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway.
Li Y; Peng F; Tan X; Wang J; Xu Y
Genes Genomics; 2021 Oct; 43(10):1189-1198. PubMed ID: 34417976
[TBL] [Abstract][Full Text] [Related]
12. WNT5A Promoter Methylation Is Associated with Better Responses and Longer Progression-Free Survival in Colorectal Cancer Patients Treated with 5-Fluorouracil-Based Chemotherapy.
Jiang G; Lin J; Wang W; Sun M; Chen K; Wang F
Genet Test Mol Biomarkers; 2017 Feb; 21(2):74-79. PubMed ID: 28051879
[TBL] [Abstract][Full Text] [Related]
13. ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration.
Ma SS; Srivastava S; Llamosas E; Hawkins NJ; Hesson LB; Ward RL; Ford CE
BMC Cancer; 2016 Jul; 16():508. PubMed ID: 27440078
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor of DNA binding 2 knockdown inhibits the growth and liver metastasis of colorectal cancer.
Liu F; Chen S; Yu Y; Huang C; Chen H; Wang L; Zhang W; Wu J; Ye Y
Gene; 2022 Apr; 819():146240. PubMed ID: 35114275
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic silencing of NDRG2 promotes colorectal cancer proliferation and invasion.
Hong SN; Kim SJ; Kim ER; Chang DK; Kim YH
J Gastroenterol Hepatol; 2016 Jan; 31(1):164-71. PubMed ID: 26250123
[TBL] [Abstract][Full Text] [Related]
16. Van-Gogh-like 2 antagonises the canonical WNT pathway and is methylated in colorectal cancers.
Piazzi G; Selgrad M; Garcia M; Ceccarelli C; Fini L; Bianchi P; Laghi L; D'Angelo L; Paterini P; Malfertheiner P; Chieco P; Boland CR; Bazzoli F; Ricciardiello L
Br J Cancer; 2013 Apr; 108(8):1750-6. PubMed ID: 23579212
[TBL] [Abstract][Full Text] [Related]
17. LINE-1 is preferentially hypomethylated within adenomatous polyps in the presence of synchronous colorectal cancer.
Jiang AC; Buckingham L; Barbanera W; Korang AY; Bishesari F; Melson J
Clin Epigenetics; 2017; 9():25. PubMed ID: 28293326
[TBL] [Abstract][Full Text] [Related]
18. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
19. RASSF1A promotes ATM signaling and
Gao A; Bai P; Zhang M; Yao Y; Herman JG; Guo M
Epigenomics; 2023 Nov; 15(22):1205-1220. PubMed ID: 38093706
[No Abstract] [Full Text] [Related]
20. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]